FAQ on BFCH's Business Plan and Platform Vision Post-Leadership Transition

What is the main focus of BFCH’s updated business plan?

The main focus is on transforming BFCH into a restructured public platform centered on human optimization, cognitive performance, and longevity infrastructure.

Who is the new CEO of BFCH and what changes has he implemented?

Dr. Jordan P. Balencic was appointed as the new CEO and has realigned BFCH’s corporate strategy, strengthened its financial position, and initiated a rebranding to EVERMIND Holdings, Inc.

What are some of the early restructuring milestones achieved by BFCH?

BFCH has retired over $2 million in legacy convertible debt, capped dilution with a $0.01 per share fixed-price conversion ceiling, reduced total liabilities to under $94,000, and started corporate rebranding.

What does the $0.01 per share threshold represent for BFCH?

It represents a negotiated, fixed-price equity conversion to eliminate variable-rate dilution from legacy obligations and serves as a structural benchmark for future corporate activities.

What are the three divisions of the EVERMIND Holdings platform?

The three divisions are EVERMIND Labs, focused on consumer-facing wellness brands; and two others targeting scalable opportunities in cognitive performance and longevity-focused innovation, though specifics are not fully detailed in the content.

How does BFCH plan to ensure long-term value creation?

Future equity activity will be structured in alignment with measurable execution milestones and long-term value creation, focusing on disciplined growth and strategic acquisitions.

Where can investors find more information about BFCH’s strategic direction?

Investors are encouraged to conduct their own research into the total addressable market and emerging opportunities, with more details available in the newly released business plan.